Merck & Co., Inc. is 262.3x more valuable than MANNKIND CORP by market capitalization ($294.13 B vs $1.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MNKD | MRK |
|---|---|---|
| Market cap | $1.12 B | $294.13 B |
| US-listed rank | #2555 | #44 |
| Revenue (latest FY) | $348.97M | $65.01B |
| Net income (latest FY) | $5.86M | $18.25B |
| Net margin | 1.7% | 28.1% |
| P/E (trailing FY) | 191.3 | 16.1 |
| SEC filings | 1,648 | 996 |
Merck & Co., Inc. is 262.3x more valuable than MANNKIND CORP by market capitalization ($294.13 B vs $1.12 B).
In their latest fiscal years, MANNKIND CORP reported $348.97M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: MANNKIND CORP and Merck & Co., Inc., or browse the full rankings.